Post-earnings research review
The next research note will be published after relevant company filings and management guidance have been assessed.
H143 Research Journal
Ideas underactive review.
A record of company research, businesses under study and the evidence shaping H143 Capital Research’s evolving perspective.
01 — Research notes
Conclusions are continuously tested.
Notes document material thesis changes, post-earnings reviews, risk assessments and shifts in the underlying evidence.
Suja Life: It’s Not Possible, It’s Necessary
A cautious Buy research note on Suja Life after its post-IPO decline, including Q2 earnings, revised guidance, wellness-category growth, valuation scenarios and execution risks.
SARO: I Can Do This All Day
A cautious Buy research note on StandardAero, Q2 earnings quality, LEAP and CFM56 growth investments, valuation scenarios, free-cash-flow recovery and balance-sheet risks.
Honeywell Aerospace: A Small Bite of an Undercooked Steak
A research note on Honeywell Aerospace after the Q2 earnings reset, including the HONA spinoff, guidance cut, segment performance, valuation discount and supply-chain execution risk.
Stantec: Priced for Trouble, Built for Resilience
A research note on Stantec's infrastructure services platform, Page acquisition, organic-growth pressure, Q2 earnings setup and conservative balance sheet.
Oracle: The Iron Throne of AI Comes With a Heavy Debt Burden
A research note on Oracle's AI infrastructure capex, RPO backlog, debt burden, bond-market pressure and the risks behind the company’s AI strategy.
MDA Space: Built for Wanderers, Bound for the Stars
A research note on MDA Space's valuation, Blue Canyon and CLS acquisitions, backlog setup, Q2 earnings preview, technical picture and key risks.
Autodesk: Choosing Plata While the Market Reaches for Plomo
Hari Patel's original Autodesk draft, including the MaintainX acquisition reset, valuation discount, moat discussion and long-position disclosure.
Firefly Aerospace: Ambition, execution and the path to repeatability
Firefly’s expanding NASA and national-security contract base creates a credible long-term opportunity. The investment case still depends on mission execution, backlog conversion, margins and disciplined financing.
Coming soon
02 — Watchlist briefs
Research before conclusions.
Company-specific research on business quality, financial resilience, expectations, valuation and the evidence required before a thesis is strengthened or rejected.
Under active review
Rollins, Inc.
Durability at a price.
A high-quality essential-services compounder combining recurring demand, established brands and disciplined consolidation—now undergoing an unusually large valuation reset.
Read the complete research brief ↗H143 gradeA−Watchlist
Reference drawdown−33.8%From February 2026 high
Trailing P/E≈40×Premium, improving
Research statusActiveNo recommendation
Evidence before allocation
Quality, organic growth, balance-sheet resilience, valuation and explicit thesis-invalidation conditions.
Applied in every briefIn preparation
A second company-specific brief will appear after filings, earnings materials and valuation inputs have been reviewed.
Coming soon03 — Market observations
Context without prediction.
Long-term observations on valuation, market cycles, business quality and risk—not short-term trading calls.
Price and value are different questions.
Market price is immediate; intrinsic value is an estimate built from future cash generation, financial resilience and the range of plausible outcomes.
Uncertainty must be sized.
Early-stage, pre-profit and options positions require explicit attention to downside, liquidity, dilution, timing and the possibility of permanent capital loss.
Optional publication notices
Follow the research, not the noise.
Receive an email when a new Research Note, Watchlist Brief or Market Observation is published. Subscription requires express consent and email confirmation.
Important disclosure: This journal is for general informational and educational purposes only. It is not individualized investment advice, a recommendation, solicitation, or offer to buy or sell any security. Hari Patel may personally hold securities discussed; material interests are disclosed with the relevant research. Securities and opinions may change without notice. Readers must conduct independent due diligence and consult an appropriately registered adviser where advice is required.